Jeito Capital

Private Equity
Website →
USD 1.7B
Estimated FUM
Type
Private Equity
HQ
Paris, France
Focus
Healthcare & Life Sciences
Last fundraise
EUR 1B

About

Jeito Capital is a Paris-based private equity firm specializing in biopharma and healthcare, with €1.6 billion in assets under management. It supports innovative therapies through a patient-driven investment approach.

Strategies

Growth Equity
Buyout

Investment Focus

Sources

Profile sources

  1. jeito.life — Healthcare & Life Sciences

Investment Criteria

Investment Stages
Stages
Growth
Investment Geographies
Primary Markets
France
Coverage
Country-focused
Regions
Europe

Coverage is a guide only.

Location

Headquarters
Paris, France
More investors with offices in Paris
Office Presence
1 country
France
1 known office
Paris, France (HQ)

Fundraising

Jeito II
EUR 1B

Deals & Activity

Deals, last 12 months
0
None led
Deals, last 36 months
1
None led
Exits, last 36 months
0
0 on record
Most active, last 12 months
–

Recent deals

Rounds, buyouts and stakes from public sources · How this is counted
  • Series D · Jul 2024
    With Canaan (lead), Bioqube Ventures (lead), Forbion Growth Opportunities Fund and 5 more
    US$150m
Tracked deals
6
Most common deal types
Unknown (3) Growth (2) Buyout (1)

Other recorded investments

Neogene Therapeutics
2024
Neogene Therapeutics
Buyout - 2024
Neogene Therapeutics
2022
Neogene Therapeutics
Growth
Neogene Therapeutics

Similar investors

Other Private Equity Firms in Paris

Blackstone
Blackstone is a global alternative asset manager investing across private equity, real estate, credit and insurance, multi-asset, secondaries, tactical opportunities, infrastructure, life sciences, growth and energy transition strategies.
KKR
KKR is a leading global investment firm that manages multiple alternative asset classes, including private equity, energy, infrastructure, real estate, credit and hedge funds. The firm is a recognised global leader in private equity, with a long history of successful investments dating back to its founding in 1976. Although originally specialising in leveraged buy-out (control) transactions, KKR today participates in almost every asset class.
The Carlyle Group
The Carlyle Group is a global private equity and alternative asset manager headquartered in Washington DC, USA. Carlyle was founded in 1987 and has grown to become one of the largest, most well known and most respected private equity managers globally. Carlyle operates across four principal strategies: Corporate Private Equity ($75bn AUM), Real Estate and Infrastructure ($44bn AUM), Global Credit ($34bn) and Fund of Funds / Investment Solutions ($34bn AUM). Carlyle was founded in 1987, originally as an investment banking boutique, by five founders: William Conway, Stephen Norris, David Rubenstein, Daniel D'Aniello and Greg Rosenbaum. Carlyle went public through a NASDAQ listing in May 2012.
EQT
EQT Partners is a global alternative investment firm with strategies across private equity, infrastructure, real estate, growth equity, and public value.
Oaktree Capital
Oaktree Capital is one of the world's leading alternative investment managers. Oaktree has its original roots in high yielding and distressed credit/debt, although today invests across the spectrum from equity to debt. There are four primary strategies: credit, private equity, real assets, and listed equities. Credit comprises approximately 70% of the portfolio, with private equity and real assets comprising most of the remainder. Oaktree has a strong culture and investment philosophy focused on risk control, consistency, market inefficiency, specialisation, bottom-up analysis and disavowal of market timing.
Advent International
Advent International is a global private equity firm focusing on buyouts and growth equity investments across five core sectors: business and financial services, healthcare, industrial, technology, and retail/consumer.